Oslo Cancer Cluster

How do the politicians aim to increase the number of cancer trials in Norway?

🔥 Karl Kristian Bekeng (Arbeiderpartiet), Kjersti Toppe (Senterpartiet), Kristian August Eilertsen (Fremskrittspartiet/Progress Party) and Bård Ludvig Thorheim (Høyre) went head-to-head in a heated debate about cancer trials during Fremtidens kreftbehandling at Litteraturhuset in Oslo yesterday.

Key questions raised:
🚨 Does the value of a quality-adjusted life year (QALY) need to be raised to attract more trials?
🚨 Do we need to see clinical trials in relation to building the Norwegian health industry?
🚨 How can patients living in remote parts of Norway be included in trials?

The debate in the recording is in Norwegian.

Plans to boost cancer trials trigger debate Politicians agree that Norway needs more clinical studies in cancer but are at odds as to how to reach the goals.

"We will be leading; we will be the best.” Jan Christian Vestre, Minister of Health and Care Services, made some bold promises when he presented the revised action plan for clinical studies at the Norwegian Radium Hospital yesterday.

Three of his main promises were:
🔬 To make clinical research an integrated part of all patient treatment
🌎 Norway will become one of the most attractive countries for clinical studies in Europe
🚀 And will provide the easiest access to health data in the Nordics.

A central focus area was collaboration between the health services and industry. Vestre highlighted that Nortrials will be developed, along with the national feasibility portal, as well as, closing the gap between clinical trials and Nye metoder.

Vestre: “We will be leading; we will be the best” A new governmental plan makes bold promises to attract clinical studies to Norway, but will it deliver?